Home-based Gait and Balance Training in Patients With Movement Disorders
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The research project is an experimental study with three study visits at the study site at the University Hospital Düsseldorf (UKD) / Heinrich Heine University Düsseldorf (HHU) and a three-week training phase in a parallel design. Patients with movement disorders (ataxia or Parkinson\'s disease) can take part. The training phase includes individually adapted, targeted, video-based coordination and balance training, which should lead to an improvement in gait and balance. Two different training protocols are carried out in parallel for three weeks each: One with 20 minutes of training per day, four days per week; and one with a training duration of 40 minutes per day, only two days per week. All patients initially take part in a one-week familiarization phase without training and are then randomly assigned to one of the two training protocols or the control group without additional training. In both training phases, the total amount of weekly training time is the same, but the frequency and duration of training sessions per week differs. The patients who were assigned to the control group without additional training can complete the training after their third study visit.
Eligibility Criteria
Inclusion Criteria: * clinical diagnosis of cerebellar ataxia or idiopathic Parkinson's syndrome * opportunity to walk a distance of four meters unhindered at home Exclusion Criteria: * other diseases with an impact on motor skills * severe primary psychiatric illnesses * current drug or alcohol addiction * consumptive diseases * poor general condition * increased risk of falling (anamnestic fall frequency of ≥ 1x per week or as assessed by the attending physician) * incapacitated patients in official or court custody or patients unable to give consent * for PD patients taking medication: not being able to carry out the measurement in the on-phase of the medication